Defining Vitality: Associations of Three Operational Definitions of Vitality with Disability in Instrumental Activities of Daily Living and Frailty among Elderly Over a 3-Year Follow-Up (MAPT Study).


Journal

The journal of nutrition, health & aging
ISSN: 1760-4788
Titre abrégé: J Nutr Health Aging
Pays: France
ID NLM: 100893366

Informations de publication

Date de publication:
2019
Historique:
entrez: 2 4 2019
pubmed: 2 4 2019
medline: 17 6 2020
Statut: ppublish

Résumé

This study aimed to examine the associations of three operational definitions of vitality with variation in instrumental activities of daily living (IADL) and frailty over a 3-year follow-up among non-demented, community-dwelling elderly. Observational study. 1,679 elderly >70y (64.7% female) participants of the Multidomain Alzheimer Preventive Trial (MAPT). Vitality was defined as a psychological concept using three items from the Geriatric Depression Scale; as a physical construct using the highest quartile for hand grip strength; and as global physiological reservoir using a combination of good physical and cognitive functions. Variables were assessed at baseline, 6, 12, 24 and 36 months of follow-up. Prevalence of high vitality at baseline was 57.1%, 28.5% and 21.6% for psychological, physical, and physiological reservoir, respectively. People with high vitality presented higher IADL scores compared to people with low vitality for all definitions. Analysis from the mixed-effect model found no differences between vitality groups for IADL performance across all definitions. IADL scores improved among subjects with high vitality over time, independent on the definition; while no significant variation was observed among those with low vitality. Participants with low vitality presented 2.0 to 6.1 higher odds of having more frailty components over time (p<0.0001). High vitality defined as a concept related to psychological, physical, or physiological reservoir constructs were positively associated with better IADL performance and with reduced likelihood of frailty worsening over time.

Identifiants

pubmed: 30932139
doi: 10.1007/s12603-019-1175-0
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

386-392

Déclaration de conflit d'intérêts

None

Références

Age Ageing. 1999 May;28(3):283-8
pubmed: 10475865
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Aging Clin Exp Res. 2004 Dec;16(6):481-6
pubmed: 15739601
J Clin Epidemiol. 2005 Nov;58(11):1180-7
pubmed: 16223662
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4 Suppl 3):S152-69
pubmed: 17135809
J Am Geriatr Soc. 2008 Jan;56(1):37-44
pubmed: 18028344
J Geriatr Phys Ther. 2008;31(1):3-10
pubmed: 18489802
J Aging Health. 2010 Aug;22(5):589-610
pubmed: 20453156
Qual Life Res. 2011 Nov;20(9):1371-8
pubmed: 21380765
Age Ageing. 2012 Mar;41(2):155-61
pubmed: 22156556
J Am Geriatr Soc. 2012 Jan;60(1):77-85
pubmed: 22211568
J R Soc Med. 1990 Aug;83(8):486-9
pubmed: 2231574
J Gerontol A Biol Sci Med Sci. 2013 May;68(5):624-30
pubmed: 23105042
Age Ageing. 2015 Mar;44(2):269-74
pubmed: 25362503
Best Pract Res Clin Rheumatol. 2014 Jun;28(3):395-410
pubmed: 25481423
Lancet. 2015 Jul 18;386(9990):266-73
pubmed: 25982160
Geriatr Gerontol Int. 2016 Jul;16(7):829-35
pubmed: 26245307
J Prev Alzheimers Dis. 2014 Jun;1(1):13-22
pubmed: 26594639
J Frailty Aging. 2014;3(2):109-12
pubmed: 27049903
Rev Bras Enferm. 2016 Jun;69(3):478-83
pubmed: 27355296
Public Health Nutr. 2017 Apr;20(6):1046-1053
pubmed: 28112078
Lancet Neurol. 2017 May;16(5):377-389
pubmed: 28359749
Rev Med Chil. 2017 Jan;145(1):55-62
pubmed: 28393970
J Phys Ther Sci. 2017 May;29(5):880-883
pubmed: 28603364
BMJ Open. 2018 Jan 21;8(1):e018836
pubmed: 29358434
J Am Med Dir Assoc. 2018 May;19(5):391-398
pubmed: 29371128
J Gerontol A Biol Sci Med Sci. 2018 Nov 10;73(12):1653-1660
pubmed: 29408961
PLoS Med. 2018 Mar 6;15(3):e1002503
pubmed: 29509768
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Psychol Bull. 1984 May;95(3):542-75
pubmed: 6399758
Br J Psychiatry. 1982 Jun;140:566-72
pubmed: 7104545
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
World Health Organ Tech Rep Ser. 1995;854:1-452
pubmed: 8594834
J Pers. 1997 Sep;65(3):529-65
pubmed: 9327588
J Gerontol B Psychol Sci Soc Sci. 1997 Nov;52(6):P294-302
pubmed: 9403518

Auteurs

K V Giudici (KV)

Kelly Virecoulon Giudici, Gérontopôle de Toulouse, Institut du Vieillissement, 37 Allées Jules Guesdes, 31000 Toulouse, France, E-mail: kellygiudici@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH